Early adoption of lecanemab in Japan (December 2023-December 2024): Pretreatment diagnostic timelines from the DeSC claims database. - Nakashima S; Sato K; Niimi Y; Aso S; Yasunaga H; Satake W; Iwatsubo T (Journal of Alzheimer's disease : JAD, 2026)